According to Grow Therapy, "the U.S. Preventive Services Task Force released new guidelines last year urging that adults ages 19 to 64 be routinely screened for anxiety, even if they show no signs of the disorder." This encapsulates the boom in awareness of the current care gaps in mental health, as well as the pressing unmet need for these patients. Grow Therapy is a rapidly growing company (closing another $88mn in funding in Spring 2024) utilizing a "3-sided platform" - connecting patients, payers, and providers. The net impact: Grow Therapy claims to be able to treat patients within just 4 days. (July 2024)